Inamed Says Board Approves Allergan Offer
- Share via
Inamed Corp. said its board had unanimously approved Botox maker Allergan Inc.’s $3.2-billion offer in a deal that would allow Allergan to expand its wrinkle-treatment product line.
Inamed, which also makes breast implants, said it hadn’t signed the agreement, which wouldn’t be finalized until Irvine-based Allergan said it was satisfied with its investigation of Inamed’s wrinkle smoother Juvederm.
Santa Barbara-based Inamed this week agreed to pay a $90-million breakup fee to end its $2.83-billion merger deal with Medicis Pharmaceutical Corp.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.